The Italian screening program for primary congenital hypothyroidism: actions to improve screening, diagnosis, follow-up, and surveillance.
The DOI matches its OpenAlex record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The Italian screening program for primary congenital hypothyroidism (CH) is an integrated system including neonatal screening, diagnosis, treatment, follow-up, and nationwide surveillance of the disease. The aim of the Italian screening program for CH is to identify not only babies with severe permanent CH (core target), but also babies with mild persistent and transient forms of CH who could have a benefit from an early replacement therapy (secondary target). In the last years, despite the important results obtained in terms of standardization of screening and follow-up procedures, it has become clear the need of optimizing the program in order to harmonize the screening strategy and the screening procedures among Regions, and to improve the diagnostic and therapeutic approach in all affected infants. On the basis of available guidelines, the experience of the Italian screening and clinical reference centers, and the knowledge derived from the nation-wide surveillance activity performed by the Italian National Registry of Infants with CH, the Italian Society for Pediatric Endocrinology and Diabetology together with the Italian Society for the Study of Metabolic Diseases and Neonatal Screening and the Italian National Institute of Health promoted actions aimed at improving diagnosis, treatment, follow-up and surveillance of CH in our country. In this paper the most important actions to improve the Italian screening program for CH are described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Demers, L. M., & Spencer, C. A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01681.x · Cited by 460
Applications of a New Chemiluminometric Thyrotropin Assay to Subnormal Measurement*
SPENCER, C. A., LoPRESTI, J. S., PATEL, A., GUTTLER, R. B., EIGEN, A., SHEN, D., GRAY, D., & NICOLOFF, J. T. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-453 · Cited by 371 · cited 1×
“This implies that small changes in FT4 are reflected in large changes in serum TSH (9).”
BackgroundCorbetta, C., Weber, G., Cortinovis, F., Calebiro, D., Passoni, A., Vigone, M. C., Beck‐Peccoz, P., Chiumello, G., & Persani, L. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03568.x · Cited by 247
Self-citationOlivieri, A., Stazi, M. A., Mastroiacovo, P., Fazzini, C., Medda, E., Spagnolo, A., De Angelis, S., Grandolfo, M. E., Taruscio, D., Cordeddu, V., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8235 · Cited by 224 · cited 3×
“Due to the low frequency of known mutations in patients with thyroid dysgenesis, genetic testing should be initiated either in patients with a familial occurrence of thyroid dysgenesis or in patients having additional extrathyroidal congenital malformations (21, 42).”
BackgroundResultSelf-citationTillotson, S. L., Fuggle, P. W., Smith, I., Ades, A. E., & Grant, D. B. (1994) · BMJ · doi:10.1136/bmj.309.6952.440 · Cited by 177 · cited 1×
“Recent studies suggest that an early treatment (by 7-14 days of life) with the above-recommended initial doses can rapidly normalize serum TSH and FT4 levels and restore a normal intellectual outcome even in patients with severe CH (36-38).”
BackgroundSalerno, M., Militerni, R., Bravaccio, C., Micillo, M., Capalbo, D., Di Maio, S., & Tenore, A. (2002) · Thyroid · doi:10.1089/105072502753451968 · Cited by 165 · cited 1×
“Recent studies suggest that an early treatment (by 7-14 days of life) with the above-recommended initial doses can rapidly normalize serum TSH and FT4 levels and restore a normal intellectual outcome even in patients with severe CH (36-38).”
BackgroundSelf-citationSalerno, M., Micillo, M., Di Maio, S., Capalbo, D., Ferri, P., Lettiero, T., & Tenore, A. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450377 · Cited by 123 · cited 1×
“Similarly to what occurs in general population, the major factor determining height in these children is the familial genetic growth potential (39).”
BackgroundSelf-citationKempers, M. J. E., van der Sluijs Veer, L., Nijhuis-van der Sanden, M. W. G., Kooistra, L., Wiedijk, B. M., Faber, I., Last, B. F., de Vijlder, J. J. M., Grootenhuis, M. A., & Vulsma, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1209 · Cited by 122 · cited 1×
“In adolescents and young adults neuropsychiatric evaluation can be necessary in subjects with abnormalities in previous checks or in subjects in whom cognitive or behavioral symptoms not previously underlined appear (40).”
BackgroundChildren With Congenital Hypothyroidism and Their Siblings: Do They Really Differ?
Rovet, J. F. (2005) · Pediatrics · doi:10.1542/peds.2004-1492 · Cited by 98
Léger, J., Ecosse, E., Roussey, M., Lanoë, J. L., Larroque, B., & the French Congenital Hypothyroidism Study Group (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2315 · Cited by 85 · cited 2×
“Possible selective attention problems, memory deficit, fine motor and hearing impairment (46, 48) may persist through adulthood affecting their social life, selfesteem, and emotional functioning (46).”
Background
Cited by
van Trotsenburg, P., Stoupa, A., Léger, J., Rohrer, T., Peters, C., Fugazzola, L., Cassio, A., Heinrichs, C., Beauloye, V., Pohlenz, J., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0333 · Cited by 469
Self-citationOlivieri, A., Fazzini, C., Medda, E., & The Italian Study Group for Congenital Hypothyroidism (2015) · Hormone Research in Paediatrics · doi:10.1159/000369394 · Cited by 132
Self-citationCavarzere, P., Camilot, M., Popa, F. I., Lauriola, S., Teofoli, F., Gaudino, R., Vincenzi, M., & Antoniazzi, F. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1233 · Cited by 54
Delvecchio, M., Vigone, M. C., Wasniewska, M., Weber, G., Lapolla, R., Popolo, P. P., Tronconi, G. M., Di Mase, R., De Luca, F., Cavallo, L., et al. (2015) · Italian Journal of Pediatrics · doi:10.1186/s13052-015-0190-y · Cited by 22
“Introduction Congenital hypothyroidism (CH) is the most frequent endocrine disease in childhood which causes mental delay and short stature if untreated [1, 2].”
BackgroundSelf-citation
Metadata
- Authors
- Cassio, A., Corbetta, C., Antonozzi, I., Calaciura, F., Caruso, U., Cesaretti, G., Gastaldi, R., Medda, E., Mosca, F., Pasquini, E., Salerno, M., Stoppioni, V., Tonacchera, M., Weber, G., & Olivieri, A.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2013-03-01
- Volume
- 36
- Issue
- 3
- Pages
- 195-203
- DOI
- 10.3275/8849
- OpenAlex
- W1482052698
- Cited by
- 39
- References
- 18
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.